TAVR (TAVI)

JANS Article

The STS Risk Model for SAVR After TAVR

September 10, 2026 | Shrikar Modukuri

This study developed and validated an updated Society of Thoracic Surgeons (STS) risk model for surgical aortic valve replacement after a failed transcatheter aortic valve replacement (SAVR-after-TAVR), including the emergent and concomitant-procedure cases that earlier...

Video

The TAVR Heart Team in 2026: Navigating the CMS Decision | A CTSNet Webinar

September 18, 2026 | Tom C. NguyenSilver Contributor…

CTSNet hosted a webinar on September 15, 2026, titled “The TAVR Heart Team in 2026: Navigating the CMS Decision,” featuring leading surgeons Tom B. Nguyen, Michael Mack, and Tsuyoshi Kaneko,...

Podcast

The Beat With Joel Dunning Ep. 174: Surgical Treatment of Atrial Fibrillation

September 17, 2026 | Joel DunningGold ContributorSilver Commentor…

This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with James Cox, Professor of Cardiac Surgery at the Feinberg School of Medicine at Northwestern Medicine in Chicago, Illinois, USA,...

Podcast

The Beat With Joel Dunning Ep. 173: Uniportal Robotics in the UAE

September 10, 2026 | Joel DunningGold ContributorSilver Commentor

This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with Taj Mohammed Fiyaz Chowdhry, a consultant thoracic surgeon at Burjeel Specialty Hospital, Sharjah, UAE, about uniportal robotics in the...

JANS Article

The STS Risk Model for SAVR After TAVR

September 10, 2026 | Shrikar Modukuri

This study developed and validated an updated Society of Thoracic Surgeons (STS) risk model for surgical aortic valve replacement after a failed transcatheter aortic valve replacement (SAVR-after-TAVR), including the emergent...

JANS Article

5-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis

April 24, 2025 | Mateo Marin-Cuartas

The Evolut Low Risk trial demonstrated that transcatheter aortic valve replacement (TAVR) was noninferior to surgery for the primary endpoint of all-cause mortality or disabling stroke at two years. In...

JANS Article

Dealing With the Aortic Annulus: Surgical Aortic Annulus Enlargement With a Balloon Catheter

January 9, 2025 | Andre Tyszka

The treatment of aortic valve disease has evolved, and it is expected that TAVR will be available to most patients in the next few years. However, TAVR with a bioprosthesis...

JANS Article

Valve-in-Valve Transcatheter Aortic Valve Replacement Versus Isolated Redo Surgical Aortic Valve Replacement

November 26, 2024 | Jessica Luc

This study compared outcomes between patients undergoing valve-in-valve transcatheter aortic valve replacement (ViV TAVR) and redo surgical aortic valve replacement (redo SAVR) using a retrospective analysis of institutional databases, which...

JANS Article

Transcatheter Aortic-Valve Replacement for Asymptomatic Severe Aortic Stenosis—EARLY TAVR Trial

November 26, 2024 | Mateo Marin-Cuartas

The EARLY TAVR trial investigators randomly assigned patients with asymptomatic severe aortic stenosis to undergo either early transfemoral transcatheter aortic valve replacement (TAVR) or clinical surveillance. The primary end point...

JANS Article

Initial Experience With Transcatheter Aortic Valve Replacement Before and After Lung Transplant

October 31, 2024 | Mujtaba MubashirGold Contributor

The role of transcatheter aortic valve replacement (TAVR) for the treatment of aortic stenosis in the pre- and post-lung transplant population is limited. This specific patient population is considered high...

JANS Article

The Perceval Sutureless Bioprosthetic Aortic Valve: Evolution of Surgical Valve Technology

October 3, 2024 | Jessica Luc

Aortic stenosis affects more than 9 million people worldwide and is commonly treated with surgical aortic valve replacement (SAVR), which is known for producing excellent long-term outcomes. Recent advancements in...

JANS Article

Long Term Durability of Bioprosthetic Aortic Valve Replacement in Young Patients With Bicuspid Aortic Stenosis

August 8, 2024 | Mujtaba MubashirGold Contributor

Treatment of aortic stenosis due to a bicuspid aortic valve (BAV), requires a lifetime strategy due to structural valve degeneration that necessitates redo intervention, such as surgical aortic valve replacement...

JANS Article

Cross-Sectional Study on Structural Heart Training Experiences in Cardiothoracic Residency Programs

August 8, 2024 | Mujtaba MubashirGold Contributor

Transcatheter aortic valve replacement (TAVR) has surpassed surgical aortic valve replacements in volume since TAVR is now approved for patients of all surgical risk categories. This article evaluated trainees and...

LOAD MORE
ADVERTISE ON CTSNET